Benzinga | Jul 29, 2020 04:12PM EDT

Viking Therapeutics Q2 EPS $(0.13) Beats $(0.14) Estimate

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 18.18 percent decrease over losses of $(0.11) per share from the same period last year.